Regeneron Pharmaceuticals (REGN)

Operating Expenses

$2.29B

Quarterly · Period ending: · USD

REGN logo

REGN Operating Expenses

Latest reported$2.29B
REGN Quarterly Operating Expenses ($0.00 → $2.29B)
High-resolution chart · PNG

REGN operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
2,293,700,000
2,293,100,000
2,419,800,000
2,205,900,000
2,065,900,000
1,972,700,000
2,233,600,000
2,050,100,000
1,997,300,000
1,959,800,000
1,754,500,000
1,609,900,000
1,633,600,000
1,602,300,000
1,592,000,000
1,302,100,000
1,178,800,000
1,199,300,000
1,254,900,000
1,079,200,000
1,026,500,000
1,040,599,999
841,100,000
907,600,000
961,300,000
854,700,000
911,800,000
726,800,000
1,064,300,000
669,500,000
1,049,741,000
890,763,000
860,531,000
792,998,000
903,389,000
798,796,000
781,757,000
766,166,000
776,243,000
785,253,000
851,968,000
759,789,000
756,164,000
635,917,000
564,918,000
502,104,000
495,488,000
487,476,000
396,915,000
396,229,000
350,225,000
321,652,000
259,926,000
257,559,000
238,763,000
205,178,000
195,078,000
197,290,000
165,390,000
160,840,000
167,734,000
152,803,000
145,853,000
137,701,000
139,205,000
131,476,000
135,821,000
118,274,000
105,863,000
93,820,000
89,805,000
85,223,000
80,042,000
72,294,000
76,264,000
60,978,000
52,799,000
49,437,000
43,402,000
40,827,000
40,697,000
38,030,000
-204,036,000
47,335,000
46,858,000
42,058,000
39,642,000
37,012,000
40,532,000
35,971,000
37,504,000
38,251,000
37,205,000
37,849,000
37,820,000
37,105,000
33,658,000
28,875,000
32,832,000
27,500,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.